Virpax selects Kindeva Drug Delivery as development partner for Diclofenac pMDI commercialization Virpax selects Kindeva Drug Delivery as development partner for Diclofenac pMDI commercializationApr 27, 2022 admin2022-05-04T10:09:15-04:00April 27th, 2022|Media|